Western Wealth Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
20,693
+311
+2% +$25.1K 0.05% 354
2026
Q1
$1.77M Buy
20,382
+14,891
+271% +$1.43M 0.07% 298
2025
Q4
$527K Buy
5,491
+563
+11% +$54.7K 0.02% 504
2025
Q3
$469K Buy
4,928
+215
+5% +$19.8K 0.02% 460
2025
Q2
$411K Sell
4,713
-915
-16% -$77.6K 0.02% 469
2025
Q1
$506K Buy
5,628
+730
+15% +$65.3K 0.03% 388
2024
Q4
$391K Sell
4,898
-16,121
-77% -$1.4M 0.03% 439
2024
Q3
$1.89M Buy
21,019
+12,575
+149% +$1.06M 0.11% 195
2024
Q2
$665K Sell
8,444
-3,895
-32% -$319K 0.05% 299
2024
Q1
$1.08M Sell
12,339
-7,024
-36% -$599K 0.08% 219
2023
Q4
$1.6M Sell
19,363
-76
-0.4% -$5.79K 0.12% 185
2023
Q3
$1.52M Buy
19,439
+1,392
+8% +$117K 0.13% 167
2023
Q2
$1.59M Buy
18,047
+1,308
+8% +$113K 0.14% 161
2023
Q1
$1.35M Buy
16,739
+609
+4% +$49.6K 0.13% 179
2022
Q4
$1.25M Sell
16,130
-11,417
-41% -$925K 0.13% 180
2022
Q3
$2.29M Buy
27,547
+4,953
+22% +$445K 0.13% 165
2022
Q2
$2.02M Sell
22,594
-833
-4% -$84.4K 0.12% 181
2022
Q1
$2.6M Buy
23,427
+13,264
+131% +$1.4M 0.13% 164
2021
Q4
$1.05M Buy
+10,163
New +$1.18M 0.1% 186
2021
Q2
$1.56M Buy
12,565
+8,872
+240% +$1.11M 0.16% 143
2021
Q1
$436K Sell
3,693
-23
-0.6% -$2.7K 0.06% 317
2020
Q4
$435K Sell
3,716
-2,397
-39% -$264K 0.06% 276
2020
Q3
$635K Sell
6,113
-590
-9% -$59.3K 0.1% 201
2020
Q2
$615K Buy
6,703
+499
+8% +$47.9K 0.11% 188
2020
Q1
$560K Buy
6,204
+2,453
+65% +$261K 0.13% 172
2019
Q4
$426K Sell
3,751
-2,157
-37% -$237K 0.06% 256
2019
Q3
$643K Buy
5,908
+1,966
+50% +$205K 0.13% 175
2019
Q2
$385K Sell
3,942
-201
-5% -$18.4K 0.05% 263
2019
Q1
$376K Buy
4,143
+156
+4% +$14K 0.08% 243
2018
Q4
$360K Buy
+3,987
New +$373K 0.1% 219

Other funds holding MDT

Western Wealth Management's MDT Position: Q2 2026 in Review

Western Wealth Management increased its Medtronic (MDT) stake by 1.5% in Q2 2026, buying an estimated $25.1K and bringing the position to 20,693 shares worth $1.62M. The position accounts for 0.05% of the portfolio, ranked #354.

Western Wealth Management first reported a position in MDT in Q4 2018 and has held it in 30 quarters since. The position peaked at $2.6M in Q1 2022. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Western Wealth Management held 20,693 shares of Medtronic worth $1.62M as of Q2 2026.
  • Western Wealth Management bought 311 Medtronic shares in Q2 2026, an estimated $25.1K.
  • Medtronic made up 0.05% of Western Wealth Management's portfolio in Q2 2026, its #354 holding.
  • Western Wealth Management first reported a position in Medtronic in Q4 2018 and has held it in 30 quarters since.
  • Western Wealth Management's Medtronic position peaked at $2.6M in Q1 2022.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.